ISSN: 1060-1333

Journal Home

Journal Guideline

Clinical Research and Regulatory Affairs Q2 Unclaimed

Informa Healthcare United States

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Clinical Research and Regulatory Affairs is a journal indexed in SJR in Pharmacology and Pharmaceutical Science with an H index of 16. It has a best quartile of Q2. It is published in English.

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Pharmaceutical Science (Q2) Pharmacology (Q3) Pharmacology (medical) (Q3) Pharmacology (medical) (Q3)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

Clinical Research and Regulatory Affairs

-

SJR Impact factor

16

H Index

0

Total Docs (Last Year)

8

Total Docs (3 years)

0

Total Refs

6

Total Cites (3 years)

7

Citable Docs (3 years)

0

Cites/Doc (2 years)

0.0

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Drug Safety - Case Reports Q2
Cancer Biology and Therapy Q2
Journal of Pharmacological Sciences Q2
AIDS Research and Therapy Q2
Pharmacological Reports Q2

Compare this journals

Aims and Scope

Best articles by citations

A Concise View of Risk Management for Agrosecurity

Regulatory Decision-Making in the United States Based on a Single Pivotal Clinical Study: Principles and Precedents

Impact of Industry Outsourcing on Academic Medical Centers

Marketing to the Heart: A Practical Approach to Dealing with Health Care Quackery

PHARMACOKINETICS: MODEL STRUCTURE AND TRANSPORT SYSTEMS*

Child Birth Education for Adolescents: Removing the Barriers That Prevent Attendance at Child Birth Classes

E-REGULATION AND INTERNET PHARMACIES: ISSUES AND DILEMMAS

Patient Safety: Know Your Medicine, Know Your Pharmacist. Case Report: Possible Adverse Events to Herbal Medications

Comparison of effect of fasting and of five different diets on the bioavailability of single oral dose of clarithromycin 500mg extended release tablet

FDA Expectations of Cros

The Reaction of Stakeholders to the Role of the Brazilian Federal Agency for Health Plans

Opportunities to improve clinical trial design in urothelial bladder cancer

SHOW MORE ARTICLES

Generic Substitution and Bioequivalence of Sodium Valproate at Steady-State in Healthy Volunteers

ENRICHING THE FOUNDATION: ESSENTIAL DEFINITIONS AND RESOURCES: PILLARS OF DIVERSITY

Increasing Consumer Awareness of the Need for Organ Donation

Can Rural Telemedicine Help to Solve the Health Care Access Problems in Turkey?

Determination of the Efficiency of First Time-In-Man Designs in Healthy Volunteers

Privacy Issues Concerning Direct Relationship Marketing in Health Care

Successful Implementation of a Student Nurse Externship Program

PLANNING, COORDINATING, AND MONITORING CLINICAL TRIALS*

Safety and efficacy of long-term treatment with fluticasone propionate and salmeterol via DISKUS versus fluticasone propionate alone

COULD PUBLICATION OF BIOINEQUIVALENCE DATA DISCOURAGE FRAUDS ON BIOEQUIVALENCE TRIALS?

Fostering Ethical Competence in Nursing Education

Polymers Applied in Solid Dispersion Technology

Clinical Research and Regulatory Affairs Q2 Unclaimed

- €

NPD

- €

Metrics

-

16

0

8

0

6

7

0

0.0

Comments

Other journals with similar parameters

Aims and Scope

Best articles by citations

FAQS

What is the impact factor of Clinical Research and Regulatory Affairs?